Skip to content

Effect of intravenous Tranexamic acid injection on the amount of bleeding during septorhinoplasty

Effect of intravenous transamine injection (Tranexamic acid) on the amount of bleeding and the surgeon's satisfaction during septorhinoplasty

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171228038117N3
Enrollment
60
Registered
2020-04-29
Start date
2020-05-21
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Repair Nasal Septum. septorhinoplasty

Interventions

Intervention 1: Intervention group: In this group, like the control group, they go through the same anesthesia process after preparing for the surgery. Take 10 mg / kg of tranexamic acid as a loading

Sponsors

Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 50 years Anyone who need a corrective or rhinoplasty operation for the first time after examination by surgeon Candidate for septorhinoplasty for one turn

Exclusion criteria

Exclusion criteria: Demonstrate any allergic disorders during the procedure History of coagulopathies History of taking anticoagulants History of high blood pressure History of taking antihypertensive drugs Addicted to drugs

Design outcomes

Primary

MeasureTime frame
Bleeding rate. Timepoint: During Septorhinoplasty. Method of measurement: We subtract the volume of fluid added during surgery from the volume of fluid in the suction chamber.;Complications of Septorhinoplasty. Timepoint: During and after Septorhinoplasty. Method of measurement: Checklist.;Surgeon satisfaction. Timepoint: After Septorhinoplasty. Method of measurement: check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBabak Hoseinzadeh

Semnan University of Medical Sciences

babakhz.anesthesia@gmail.com+98 23 3344 1022

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026